The Science
The Science Behind LED Skin Therapy

LED phototherapy — specifically photobiomodulation using red light wavelengths — is one of the most studied non-invasive cosmetic modalities of the last two decades. This page explains what the research actually says, what 630nm red light does at the cellular level, and why consistent home use produces meaningful cosmetic results over a 12-week protocol.
630nm Red Light
What 630nm red light does: Red light at approximately 630nm penetrates to the dermal layer of the skin, where it is absorbed by mitochondria in skin cells (specifically through a chromophore called cytochrome c oxidase). This absorption has been associated in peer-reviewed research with increased fibroblast activity — the cellular process responsible for collagen synthesis.
Published studies on 630nm red light therapy document improvements in:
- The visible appearance of fine lines and wrinkles
- Skin texture and surface quality
- Skin tone evenness and luminosity
Additional Wavelength Modes
Beyond 630nm, the Radiant Glow includes 460nm (blue) and 520nm (green) wavelengths in six additional modes. These address complementary skin concerns:
- 460nm (blue): supports the appearance of clearer, calmer skin
- 520nm (green): supports a more even-toned complexion
- Combined modes (purple, yellow, cyan, white): target multiple concerns in one session
The device offers seven total modes, allowing you to tailor each session to what your skin needs — using 630nm red as the foundation for the primary anti-ageing protocol.
Why Consistency Matters
The published evidence on LED phototherapy is consistent on one variable: results accumulate over time and are directly correlated with session frequency. Most peer-reviewed studies use protocols of 3–5 sessions per week over 8–12 weeks. This is why Lumechor is designed for daily home use — not to replace a clinic, but to achieve consistent cumulative exposure that produces comparable cosmetic outcomes.
Footer note: All claims on this page and on lumechor.com reflect the appearance of skin and are made in the context of cosmetic use. Lumechor devices are not intended to diagnose, treat, cure, or prevent any medical condition. References to published research reflect third-party findings — not Lumechor clinical trials.
Scientific References
1. Biological and Therapeutic Responses of Human Skin to Different Wavelengths of Light (2024): A comprehensive review highlighting that red light and near-infrared light have the strongest clinical evidence for promoting wound healing, anti-aging, and skin rejuvenation through photobiomodulation.
View on PMC
2. Exploring the Safety and Efficacy of Light-Emitting Diodes in Skin Rejuvenation (2024): This study established the effectiveness of LED irradiation in upregulating collagen and growth factor expression while downregulating matrix metalloproteinases (MMPs), correlating with a visible reduction in skin wrinkles.
View on PMC
3. Photobiomodulation: Clinical applications in dermatology (2024): A clinical review affirming that photobiomodulation (specifically utilizing the red light spectrum) is a safe, effective, and noninvasive modality for skin rejuvenation and increasing fibroblast activity.
View on PubMed